PMID- 31435382
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231013
IS  - 1658-3612 (Electronic)
IS  - 1658-3612 (Linking)
VI  - 13
IP  - 6
DP  - 2018 Dec
TI  - Development of type 2 diabetes mellitus after gestational diabetes in a cohort in 
      KSA: Prevalence and risk factors.
PG  - 582-586
LID - 10.1016/j.jtumed.2018.11.004 [doi]
AB  - OBJECTIVES: KSA has the highest prevalence of diabetes mellitus among Middle 
      Eastern countries with a prevalence range of 21%-24%. Gestational diabetes (GDM) 
      is a well-known risk factor for type 2 diabetes mellitus (T2DM). GDM is 
      associated with a 7-fold increased risk of T2DM. Thus, this research assessed the 
      prevalence and risk factors associated with the development T2DM in a cohort of 
      patients with GDM in KSA. METHODS: The medical records of patients with GDM who 
      visited the outpatient clinics of a tertiary care hospital from 2011 to 2014 were 
      included in this study. Patients with a prior diagnosis of diabetes mellitus 
      before pregnancy and those with GDM who did not have postpartum diabetes 
      screening were excluded. RESULTS: A total of 123 women with GDM and underwent 
      postpartum diabetes screening, 82 (67%) developed T2DM based on follow-up 
      records. Approximately 45% (37/82) of patients who developed T2DM were screened 
      </=6 months after delivery, whereas 55%(45/82) were screened >6 months after 
      delivery. Older patients, patients who had a higher number of pregnancies 
      (gravidity and parity), and patients with previous GDM were more likely to 
      develop T2DM. CONCLUSION: In KSA, women who developed GDM, particularly those who 
      are older, multigravid, and multiparous and who have a prior history of GDM, are 
      at an increased risk of developing T2DM. Postpartum diabetes screening of 
      patients with GDM within the recommended period need to be improved.
FAU - Mahzari, Moeber M
AU  - Mahzari MM
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
AD  - Department of Medicine, Division of Endocrinology - Ministry of National Guard - 
      Health Affairs, KSA.
AD  - King Abdullah International Medical Research Center, KSA.
FAU - Alwadi, Fahad A
AU  - Alwadi FA
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
FAU - Alhussain, Basil M
AU  - Alhussain BM
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
FAU - Alenzi, Tariq M
AU  - Alenzi TM
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
FAU - Omair, Aamir A
AU  - Omair AA
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
FAU - Al Dera, Hussain S
AU  - Al Dera HS
AD  - King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, KSA.
LA  - eng
PT  - Journal Article
DEP - 20181207
PL  - Saudi Arabia
TA  - J Taibah Univ Med Sci
JT  - Journal of Taibah University Medical Sciences
JID - 101621911
PMC - PMC6695016
OTO - NOTNLM
OT  - Gestational diabetes
OT  - Postpartum
OT  - Risk factors
OT  - Screening
OT  - Type 2 diabetes
EDAT- 2019/08/23 06:00
MHDA- 2019/08/23 06:01
PMCR- 2018/12/07
CRDT- 2019/08/23 06:00
PHST- 2018/06/25 00:00 [received]
PHST- 2018/11/04 00:00 [revised]
PHST- 2018/11/06 00:00 [accepted]
PHST- 2019/08/23 06:00 [entrez]
PHST- 2019/08/23 06:00 [pubmed]
PHST- 2019/08/23 06:01 [medline]
PHST- 2018/12/07 00:00 [pmc-release]
AID - S1658-3612(18)30118-5 [pii]
AID - 10.1016/j.jtumed.2018.11.004 [doi]
PST - epublish
SO  - J Taibah Univ Med Sci. 2018 Dec 7;13(6):582-586. doi: 
      10.1016/j.jtumed.2018.11.004. eCollection 2018 Dec.